bluebird bio
Rick Riley is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Director of Qualified Treatment Center Engagement at bluebird bio since December 2021. Previously, Rick worked as a Hematology Clinical Account Specialist at Pharmacyclics, an AbbVie Company, from April 2020 to December 2021. Prior to that, Rick spent eight years at Genentech, first as a Senior Clinical Oncology Specialist focusing on lung and bladder tumors, and later as a Senior Clinical Specialist with expertise in rare disease, immunology, and dermatology.
This person is not in any teams
bluebird bio
40 followers
bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Its vision is to make the hope of gene therapy a reality.